MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hide, I.
Right arrow Articles by Daly, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hide, I.
Right arrow Articles by Daly, J. W.

A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase

I Hide, WL Padgett, KA Jacobson and JW Daly

Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Binding assays and assays of activation of adenylate cyclase with the agonists 5'-N-ethylcarboxyamidoadenosine (NECA) and CGS21680 have been used to compare adenosine receptors in rat pheochromocytoma PC12 cells and in rat striatum. The [3H]NECA binding showed two components, whereas [3H]CGS21680 bound to one component in both tissues. The Kd value for the high affinity site labeled with [3H]NECA in PC12 cell membranes (2.3 nM) was lower than that in striatum (6.5 nM). The [3H]CGS21680 binding site showed a Kd value of 6.7 nM and 11.3 nM in PC12 cells and striatum, respectively. In the presence of GTP the KD values of [3H]NECA and [3H]CGS21680 for the high affinity site were increased severalfold, whereas the low affinity sites for [3H]NECA were no longer detected with filtration assays. A comparison of the ability of a series of agonists and antagonists to inhibit high affinity binding of [3H]NECA to A2 receptors in PC12 cell and striatal membranes indicated that agonists had higher affinities and antagonists had lower affinities in PC12 cells, compared with affinities in striatal membranes. Analysis of activation of adenylate cyclase in PC12 cell membranes suggested that the dose-dependent stimulation by NECA involved two components, whereas CGS21680 stimulated via one component. The maximal stimulation by NECA significantly exceeded that caused by CGS21680. In intact PC12 cells, NECA caused a greater accumulation of AMP than did CGS21680, as was the case in membranes. In striatal membranes, NECA and CGS21680 showed similar maximal stimulations of adenylate cyclase. Both NECA and CGS21680 were more potent in PC12 cell membranes than in striatal membranes, in agreement with binding data. However, in contrast to binding data, antagonists were not less potent versus stimulation of adenylate cyclase by NECA or CGS21680 in PC12 cell membranes, compared with striatal membranes. In toto, the results suggest that A2A receptors in striatum are virtually identical to the A2A receptors in PC12 cells. But, in addition to an A2A receptor, it appears that a lower affinity functional receptor, probably an A2B receptor, is present in PC12 cells and PC12 cell membranes, whereas such a functional low affinity receptor is not detectable in striatal membrane.

Volume 41, Issue 2, pp. 352-359, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. Yang, V. R. Tuniki, S. Anjaiah, J. R. Falck, C. J. Hillard, and W. B. Campbell
Characterization of Epoxyeicosatrienoic Acid Binding Site in U937 Membranes Using a Novel Radiolabeled Agonist, 20-125I-14,15-Epoxyeicosa-8(Z)-Enoic Acid
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1019 - 1027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. A. Erdmann, Z.-G. Gao, U. Jung, J. Foley, T. Borenstein, K. A. Jacobson, and D. H. Fowler
Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
Blood, June 15, 2005; 105(12): 4707 - 4714.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. Nash and J. M. Brotchie
A Common Signaling Pathway for Striatal NMDA and Adenosine A2a Receptors: Implications for the Treatment of Parkinson's Disease
J. Neurosci., October 15, 2000; 20(20): 7782 - 7789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Kobayashi, L. Conforti, and D. E. Millhorn
Gene expression and function of adenosine A2A receptor in the rat carotid body
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L273 - L282.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Greney, P. Ronde, C. Magnier, F. Maranca, C. Rascente, W. Quaglia, M. Giannella, M. Pigini, L. Brasili, C. Lugnier, et al.
Coupling of I1 Imidazoline Receptors to the cAMP Pathway: Studies with a Highly Selective Ligand, Benazoline
Mol. Pharmacol., June 1, 2000; 57(6): 1142 - 1151.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Florio, F. Frausin, R. Vertua, and R. M. Gaion
Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens
5-(N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1877 - H1883.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Belardinelli, J. C. Shryock, S. Snowdy, Y. Zhang, A. Monopoli, G. Lozza, E. Ongini, R. A. Olsson, and D. M. Dennis
The A2A Adenosine Receptor Mediates Coronary Vasodilation
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1066 - 1073.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
I. Feoktistov and I. Biaggioni
Adenosine A2B Receptors
Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Zhang, L. Belardinelli, K. A. Jacobson, D. H. Otero, and S. P. Baker
Persistent Activation by and Receptor Reserve for an Irreversible A1-Adenosine Receptor Agonist in DDT1 MF-2 Cells and in Guinea Pig Heart
Mol. Pharmacol., September 1, 1997; 52(3): 491 - 498.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
L. Belardinelli, J. C. Shryock, J. Ruble, A. Monopoli, S. Dionisotti, E. Ongini, D. M. Dennis, and S. P. Baker
Binding of the Novel Nonxanthine A2A Adenosine Receptor Antagonist [3H]SCH58261 to Coronary Artery Membranes
Circ. Res., December 1, 1996; 79(6): 1153 - 1160.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Kim, Jür. Wess, A. M. v. Rhee, T. Schöneberg, and K. A. Jacobson
Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A[IMAGE] Adenosine Receptor
J. Biol. Chem., June 9, 1995; 270(23): 13987 - 13997.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. T. Liang and B. Haltiwanger
Adenosine A2a and A2b Receptors in Cultured Fetal Chick Heart Cells : High- and Low-Affinity Coupling to Stimulation of Myocyte Contractility and cAMP Accumulation
Circ. Res., February 1, 1995; 76(2): 242 - 251.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Klemke, H. A. Pasolli, R. H. Kehlenbach, S. Offermanns, G. Schultz, and W. B. Huttner
Characterization of the Extra-large G Protein alpha -Subunit XLalpha s. II. SIGNAL TRANSDUCTION PROPERTIES
J. Biol. Chem., October 20, 2000; 275(43): 33633 - 33640.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics